All Entities (500)
Every published entity page, grouped by category.
Anatomy (1)
Biological Process (18)
Cellular Component (15)
Chemical (62)
- (RS)-ketamine
- Aminolevulinic acid
- Andrographolide
- Apigenin
- Berberine
- Bioactive compounds
- Bisphenol A
- Calcium
- Camptothecin
- Cannabidiol
- Chitosan
- Compound 2
- Copper
- Curcumin
- Cyclosporine
- Cysteine
- Denosumab
- DL-homocysteine
- Dopamine
- Epigallocatechin gallate
- Ethanol
- Ferulic acid
- Gallic acid
- Glucose
- Glutathione
- Hyaluronic acid
- Hydrogen peroxide
- Hydrogen sulfide
- Indocyanine green
- Irinotecan
- Kaempferol
- L-glutamine
- Lipid
- Luteolin
- Messenger RNA
- Nitric Oxide
- Oxygen
- Paracetamol
- Pectin
- Phenylalanine
- Polyethylene glycol
- Polysaccharide
- Progesterone
- Quercetin
- Reactive oxygen species
- Resveratrol
- Rosmarinic acid
- Scaffold
- Selenium
- Selenium nanoparticles
- Silver
- Silver nanoparticles
- Small interfering RNA
- Sodium
- Taurine
- Testosterone
- Trastuzumab deruxtecan
- Trimethylamine oxide
- Uric acid
- Vitamin C
- Zinc
- Zinc oxide nanoparticles
Clinical Metric (16)
Disease (50)
- Acute kidney injury
- Acute myeloid leukemia
- Alzheimer's disease
- Anxiety
- Atrial fibrillation
- Breast cancer
- Cancer
- Cardiovascular disease
- Chronic kidney disease
- Cognitive decline
- Colorectal cancer
- COVID-19
- Dementia
- Depression
- Diabetes
- Diabetic nephropathy
- Diabetic retinopathy
- Fibrosis
- Gestational diabetes
- Glioblastoma
- Glioma
- Head and neck cancer
- Heart failure
- Hepatitis B
- Hepatocellular carcinoma
- Hypertension
- Influenza
- Ischemic stroke
- Lung cancer
- Melanoma
- Metabolic dysfunction associated steatohepatitis
- Metabolic dysfunction–associated steatotic liver disease
- Mild cognitive impairment
- Non-small cell lung cancer
- Obesity
- Oral mucositis
- Oral squamous cell carcinoma
- Osteoporosis
- Ovarian cancer
- Pancreatic cancer
- Prostate cancer
- Respiratory syncytial virus
- Sarcopenia
- Stomach cancer
- Stroke
- Triple-negative breast cancer
- Type 2 diabetes
- Type-1 diabetes
- Ulcerative colitis
- Wound
Gene (24)
- BRAF
- BRAF V600E
- CTNNA1
- Cystic fibrosis transmembrane conductance regulator
- DNA
- EGFR
- Enhancer of zeste 2 polycomb repressive complex 2 subunit
- ESR1
- GSK3B
- Heme oxygenase 1
- Interleukin 10
- Iron
- KRAS
- KRAS G12C
- KRAS G12D
- MIR21
- Myc
- NAMPT
- PIK3CA
- Platelet-derived growth factor receptor alpha
- Tnf
- TP53
- Triggering receptor expressed on myeloid cells 2
- Vascular endothelial growth factor
Organism (13)
Other (5)
Pathway (8)
Protein (129)
- Acetylcholinesterase (AChE)
- Acyl-CoA synthetase long-chain family member 4 (ACSL4)
- Adiponectin (APN)
- AKT1
- Alpha-fetoprotein (AFP)
- AMP-activated protein kinases
- Amylase
- Amyloid beta (Aβ)
- Anaplastic Lymphoma Kinase (ALK)
- Androgen receptor
- Androgen receptor (AR)
- Angiotensin-converting enzyme 2 (ACE2)
- B cell maturation antigen (BCMA)
- B-cell Maturation Antigen
- B7 homolog 3 (B7-H3)
- BCL2 apoptosis regulator
- Beta-secretase 1 (BACE1)
- Bromodomain-containing protein 4 (BRD4)
- Bruton tyrosine kinase (BTK)
- Butyrylcholinesterase (BCHE)
- C-C motif chemokine ligand 2
- c-Met
- C-reactive protein (CRP)
- C-X-C motif chemokine ligand 8 (CXCL8)
- C-X-C motif chemokine receptor 4
- Calcitonin gene-related peptide (CGRP)
- Carbonic anhydrase (CA)
- Carbonic anhydrase IX (CA IX)
- Carcinoembryonic antigen (CEA)
- Cas12a
- Caspase-1 (CASP1)
- Caspase-3 (CASP3)
- Catalase (CAT)
- CD20
- CD274 molecule
- CD3+
- CD44
- Chimeric antigen receptor
- Cluster of Differentiation 19 (CD19)
- Cluster of Differentiation 28 (CD28)
- Cluster of Differentiation 47 (CD47)
- Collagen
- Cyclin-dependent kinase 1 (CDK1)
- Cyclin-dependent kinase 2 (CDK2)
- Cyclooxygenase 2 (COX-2)
- Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)
- Dipeptidyl peptidase 4 (DPP-4)
- DNA topoisomerase I
- DNMT1
- ERBB2
- FGF21
- Fibroblast activation protein
- Fibroblast Activation Protein alpha (FAP)
- Focal adhesion kinase (FAK)
- Forkhead box O3 (FOXO3)
- Galectin-3 (LGALS3)
- Glial fibrillary acidic protein
- Glucagon-like peptide-1 (GLP-1)
- Glucagon-like peptide-1 receptor (GLP-1R)
- Glucose-6-phosphate dehydrogenase
- Glucose-dependent insulinotropic polypeptide (GIP)
- Glucosidase
- Glutamate carboxypeptidase II (GCPII)
- Glutathione Peroxidase 4 (GPX4)
- Glypican-3 (GPC3)
- Heat shock protein 90-alpha (Hsp90α)
- Hemagglutinin
- High mobility group box 1 (HMGB1)
- Histone deacetylase
- Histone deacetylase 6 (HDAC6)
- Human epidermal growth factor receptor 2 (HER2)
- Human serum albumin
- Hypoxia inducible factor 1 subunit alpha
- Indoleamine 2,3-dioxygenase 1 (IDO1)
- Insulin
- Insulin like growth factor binding protein 3
- Interferon
- Interferon gamma (IFNG)
- Interleukin 17A (IL-17A)
- Interleukin-1β (IL-1β)
- Interleukin-6 (IL-6)
- JAK2
- Kelch-like ECH-associated protein 1 (KEAP1)
- KLF4
- Leptin (LEP)
- Lipocalin 2 (LCN2)
- Matrix Metalloproteinase-9 (MMP-9)
- Mechanistic target of rapamycin (mTOR)
- MEK
- Met
- Mitogen-Activated Protein Kinase 1 (MAPK1)
- MYC proto-oncogene (MYC)
- Myeloperoxidase
- Nanozyme
- Neurofilament Light Chain (NF-L)
- NLRP3
- NLRP3 inflammasome
- Nuclear factor erythroid 2-related factor 2 (NRF2)
- Nuclear receptor subfamily 1 group H member 4 (NR1H4)
- p-Tau217
- PD-L1
- Peptides
- Phosphatase and Tensin Homolog (PTEN)
- Phosphatidylinositol 3-kinase (PI3K)
- PIEZO1
- Platelet glycoprotein 4 (CD36)
- Poly(ADP-ribose) polymerase 1 (PARP1)
- Programmed cell death 1 (PD-1)
- Prostate specific membrane antigen
- Protein kinase B (PKB)
- Protein tyrosine phosphatase non-receptor type 1 (PTPN1)
- RAS
- Receptor-binding domain
- Signal Transducer and Activator of Transcription 3 (STAT3)
- SIRT1
- Spleen tyrosine kinase (SYK)
- STING
- Superoxide Dismutase (SOD)
- T-cell receptor (TCR)
- Toll like receptor 2
- Toll-like receptor 4 (TLR4)
- Toll-like receptor 7/8
- Transforming growth factor beta (TGF-β)
- Tumor necrosis factor-α (TNF-α)
- Tumor-associated calcium signal transducer 2 (TACSTD2)
- Tyrosinase (TYR)
- Vascular endothelial growth factor receptor 2 (VEGFR2)
- VEGFR-2
- Yes-associated protein 1 (YAP1)
Technology (7)
Therapy (152) cluster tree →
- (S)-(−)-colchicine
- Abemaciclib
- Adalimumab
- Adjuvant chemotherapy
- Allogeneic hematopoietic stem cell transplantation
- Anchusin
- Anti-PD-1 therapy
- Anti-PD-L1
- Antibiotic
- Antibody-drug conjugate
- Antimicrobial
- Aspirin
- Atezolizumab
- Atorvastatin
- Automated Insulin Delivery
- Belimumab
- Bevacizumab
- Bispecific antibodies
- Bortezomib
- Botulinum toxin type A
- Cabotegravir
- Cabozantinib
- Caelyx
- Capecitabine
- CAR-T cells
- Carboplatin
- Ceftazidime-avibactam
- Celastrol
- Celecoxib
- Cetuximab
- Checkpoint inhibitor
- Chemoimmunotherapy
- Chemoradiotherapy
- Chimeric Antigen Receptor T-cell therapy
- Ciprofloxacin
- Cisplatin
- Cisplatin/fluorouracil
- Cognitive behavioral therapy
- Combination therapy
- Continuous positive airway pressure
- COVID-19 vaccine
- Cyclin-dependent kinase 4/6 inhibitors
- Cyclophosphamide
- Dapagliflozin
- Daratumumab
- Dasatinib
- Deep brain stimulation
- Dexamethasone
- Direct oral anticoagulants
- Docetaxel
- Dolutegravir
- Doxorubicin
- Doxycycline
- Dupilumab
- Durvalumab
- Electroacupuncture
- Empagliflozin
- Enfortumab vedotin
- Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
- Erlotinib
- Fenofibrate
- Finerenone
- Fluorouracil
- Gemcitabine
- Gene therapy
- Glucagon-like peptide-1 agonist
- Glucocorticoid
- Histone deacetylase inhibitors
- HPV vaccination
- HPV vaccine
- Ibrutinib
- Ibuprofen
- Imatinib
- Immunization
- Immunotherapy
- Infliximab
- Influenza vaccination
- Influenza vaccine
- Insulin Therapy
- Ipilimumab
- Janus kinase inhibitors
- Lenalidomide
- Lenvatinib
- Levodopa
- Liraglutide
- Liver transplantation
- Melatonin
- Meropenem
- Mesalazine
- Metformin
- Methotrexate
- Methylprednisolone
- Monoclonal antibody
- Neoadjuvant chemotherapy
- Niraparib
- Nirsevimab
- Nivolumab
- Ocrelizumab
- Olaparib
- Osimertinib
- Oxaliplatin
- Paclitaxel
- PARP inhibitor
- PD-1/PD-L1 blockade
- Pembrolizumab
- Photobiomodulation
- Photothermal therapy
- Platelet-rich plasma
- Platinum
- Pneumococcal conjugate vaccine
- Prodrug
- Propofol
- Propranolol
- Proprotein convertase subtilisin/kexin type 9 inhibitors
- Proteolysis-targeting chimeras
- Proton therapy
- Radiation therapy
- Recombinant zoster vaccine
- Resection
- Resmetirom
- Rifampicin
- Rituximab
- RNA vaccine
- Robot-assisted radical prostatectomy
- Romosozumab
- Rutin
- Ruxolitinib
- Semaglutide
- Simvastatin
- Sirolimus
- Small molecule inhibitors
- Sodium glucose cotransporter-2 (SGLT2) inhibitors
- Sorafenib
- Statin
- Stereotactic radiosurgery
- Sunitinib
- Tacrolimus
- Tamoxifen
- Taxane
- Temozolomide
- Tirzepatide
- Tislelizumab
- Tocilizumab
- Tofacitinib
- Trastuzumab
- Tyrosine-kinase inhibitor
- Upadacitinib
- Ustekinumab
- Vancomycin
- Venetoclax
- Vitamin D
- Vorinostat